Allogeneic Hematopoietic Cell Transplantation Using Treosulfan-Based Conditioning for Treatment of Marrow Failure Disorders.
第一作者:
Lauri M,Burroughs
第一单位:
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington; Department of Pediatrics, University of Washington School of Medicine, Seattle, Washington; Department of Medicine, University of Washington School of Medicine, Seattle, Washington; Hematology-Oncology, Seattle Children's Hospital, Seattle, Washington. Electronic address: lburroug@fhcrc.org.
作者:
主题词
青少年(Adolescent);抗淋巴细胞血清(Antilymphocyte Serum);骨髓疾病(Bone Marrow Diseases);白消安(Busulfan);儿童(Child);儿童, 学龄前(Child, Preschool);无病生存(Disease-Free Survival);女(雌)性(Female);移植物存活(Graft Survival);造血干细胞移植(Hematopoietic Stem Cell Transplantation);人类(Humans);婴儿(Infant);男(雄)性(Male);移植预处理(Transplantation Conditioning);移植, 同种(Transplantation, Homologous);治疗结果(Treatment Outcome);阿糖腺苷(Vidarabine);青年人(Young Adult)
DOI
10.1016/j.bbmt.2017.06.002
PMID
28602958
发布时间
2019-01-16
- 浏览55
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



